Research Briefs: Robotic And Laparoscopic Prostatectomy Prove Safe; CorPath Announces Post-Market Study Of Robot PCI System
This article was originally published in The Gray Sheet
Executive Summary
Minimally invasive prostatectomy compares favorably to open surgery in analysis of contemporary practice data. Corindus launches post-market registry of CorPath 200 coronary intervention system
You may also be interested in...
Remote PCI: Corindus Explores Performing Cardiac Caths From Miles Away With Robotics
Corindus Vascular Robotics, Sanford Health and Helmsley Charitable Trust are partnering on a study of remote robotic-assisted PCI for patients in rural areas.
Lotus Launches In Europe: Boston Scientific Joins Crowded TAVR Field
The firm announced the CE mark and European launch of its transcatheter aortic heart valve replacement device Oct. 28. Boston is one of at least seven firms with a TAVR device now on the market in Europe.
Research Briefs: Underreporting Robot Surgery Events; AFib, Lung-Cancer Studies
A review of court records and media reports finds several robotic surgery adverse event reports that do not appear in FDA’s public records. DECAAF shows DE-MRI can guide atrial fibrillation ablation. The PanCan study identifies predictors of lung cancer.